MicroRNAs are endogenous single-stranded non-coding small RNA molecules that can be
secreted into the circulation and exist stably. They usually exhibit aberrant expression under …

Urine markers to detect bladder cancer have been the subject of research for decades. The
idea that urine—being in continuous contact with tumour tissue—should provide a vector of …

Bladder cancer (BC) ranks as the sixth most prevalent cancer in the world, with a steady rise
in its incidence and prevalence, and is accompanied by a high morbidity and mortality. BC is …

Background Early detection of cancers improves patients' survival and decreases the
treatment cost. Unfortunately, the current methods for diagnosis of bladder and prostate …

MicroRNAs (miRNAs) are small, non-coding RNAs that regulate gene expression
predominantly by inhibiting transcription and/or promoting degradation of target mRNAs also …

Bladder cancer (BC) is a clinical challenge worldwide with late clinical presentation, poor
prognosis, and low survival rates. Traditional cystoscopy and tissue biopsy are routine …

Bladder cancer (BC) is the fifth most common cancer worldwide and is associated with
significant morbidity and mortality. The prognosis of muscle invasive BC is poor, and …

Precision oncology aims to tailor clinical decisions specifically to patients with the objective
of improving treatment outcomes. This can be achieved by leveraging omics information for …

Bladder cancer (BC) is the second highest morbid malignancy of the urinary tract and the
fifth most common cancer worldwide. BC is highly malignant with significant morbidity and …

ABSTRACT Introduction: Non-coding RNAs (ncRNAs) are important regulators of cellular
signaling in tumor-related processes. They can not only be detected in tumor tissues, but …